Lactoferrin

For research use only. Not for therapeutic Use.

  • CAT Number: I040860
  • CAS Number: 936541-36-5
  • Purity: ≥95%
Inquiry Now

Lactoferrin is a substance released by neutrophils. Lactoferrin is an orally active multifunctional iron binding glycoprotein. Lactoferrin prevents cell adhesion, growth and spreading of cell colonies. Lactoferrin also has antiviral activity and inhibits microbial and viral adhesion and entry into host cells. Besides, Lactoferrin has anti-inflammatory, immunomodulatory, and anti-cancer activities[1][2][3].
Lactoferrin (0-1 000 μg/mL, 7 days) inhibits epithelial cell (HaCaT) growth in a dose-dependent manner[1].
Lactoferrin (500 μg/mL, 12 days) inhibits the spreading and growth of HaCaT cell colonies[1].
Lactoferrin (1.41 μM and 0.12 μM for human and bovine Lactoferrins) inhibits HSV-1 infection in vero cells by 50%[4].
Lactoferrin (recombinant human lactoferrin) (1,000 mg/kg, oral gavage, twice daily for 8 days) inhibits the growth of squamous cell carcinoma (O12) tumors in T cell–immunocompromised nu/nu mice by 80%[5].
Lactoferrin (Bovine lactoferrin) (100 and 200 mg/kg, oral gavage,for 30 consecutive days) shows protective effects in a rat model of sepsis-induced acute lung injury[6].


Catalog Number I040860
CAS Number 936541-36-5
Purity ≥95%
Reference

[1]. Pöllänen MT, et al. Lactoferrin impedes epithelial cell adhesion in vitro. J Periodontal Res. 1998 Jan;33(1):8-16.
 [Content Brief]

[2]. Berlutti F, et al. Antiviral properties of lactoferrin–a natural immunity molecule. Molecules. 2011 Aug 16;16(8):6992-7018.
 [Content Brief]

[3]. Cutone A, et al. Lactoferrin’s Anti-Cancer Properties: Safety, Selectivity, and Wide Range of Action. Biomolecules. 2020 Mar 15;10(3):456.
 [Content Brief]

[4]. Marchetti M, et al. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 1996 Mar;29(2-3):221-31.
 [Content Brief]

[5]. Varadhachary A, et al. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer. 2004 Sep 1;111(3):398-403.
 [Content Brief]

[6]. Han N, et al. Effect of bovine lactoferrin as a novel therapeutic agent in a rat model of sepsis-induced acute lung injury. AMB Express. 2019 Oct 31;9(1):177.
 [Content Brief]

Request a Quote